Breaking News: Is Silk Road Medical's $27.50 Per Share Sale Price a Fair Deal? Johnson Fistel, LLP Investigates Deal Terms

Shareholders of Silk Road Medical are encouraged to contact Johnson Fistel to discuss their legal rights in this matter. You can click or copy and paste the following link to join this investigation: Johnson Fistel, LLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content. On June 18, 2024, Silk Road Medical informed the public that it has agreed to a deal with Boston Scientific, in which shareholders will receive $27.50 per share ...